Related Experiment Video
Updated: Aug 6, 2025
Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
[Diagnosis and treatment of incomplete Kawasaki disease in children]
Fu-Yong Jiao1, Zhi-Long Mu1, Zhong-Dong DU
1Shaanxi Provincial Kawasaki Disease Treatment Center/Children's Hospital of Shaanxi Provincial People's Hospital, Xi'an 710068, China.
Insights
Incomplete Kawasaki disease (IKD) lacks clear diagnostic criteria, delaying treatment and increasing risks. This review clarifies IKD diagnosis and management to improve patient outcomes.
Area of Science:
- Pediatrics
- Rheumatology
- Immunology
Background:
- Kawasaki disease (KD) is a critical pediatric illness causing vasculitis in medium and small vessels.
- Early diagnosis of KD, particularly incomplete Kawasaki disease (IKD), remains challenging due to a lack of specific biomarkers.
- Delayed diagnosis of IKD can lead to severe coronary artery abnormalities.
Approach:
- This article provides a comprehensive review of IKD.
- It covers epidemiological features, diagnostic challenges, and current treatment strategies.
- The review emphasizes the importance of timely identification and standardized management.
Key Points:
- IKD diagnosis is difficult, lacking established criteria.
- Standardized treatment protocols for IKD are not clearly defined.
- Improved understanding of IKD is crucial for preventing long-term complications.
Conclusions:
- Early and accurate diagnosis of IKD is essential for effective treatment.
- This review aims to enhance clinical understanding and management of IKD.
- Standardizing IKD diagnosis and treatment can mitigate the risk of coronary artery lesions.
Abstract:
Kawasaki disease (KD) is a febrile disease mainly observed in children aged <5 years, with medium- and small-vessel vasculitis as the main lesion. Although KD has been reported for more than 50 years and great progress has been made in the etiology and pathology of KD in recent years, there is still a lack of specific indicators for the early diagnosis of KD, especially with more difficulties in the diagnosis of incomplete Kawasaki disease (IKD). At present, there are no clear diagnostic criteria for IKD, which leads to the failure of the timely identification and standardized treatment of IKD in clinical practice and even induce the development of coronary artery lesion. This article reviews the concept, epidemiological features, diagnosis, treatment, and follow-up management of IKD, in order to deepen the understanding of IKD among clinical workers and help to improve the clinical diagnosis and treatment of KD in China.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
01:26Mitral Stenosis III: Medical Management
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:14Myocarditis III: Medical Management
01:28Chronic Kidney Disease III: Interprofessional Care
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...